04 Feb 2014

Decision in the case of Manel Pérez Esteve


ITF Anti-Doping

London, England, 4 February 2014 - The International Tennis Federation announced today that Manel Pérez Esteve has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a player’s sample).

Mr Pérez Esteve, a 19-year-old tennis player from Spain, provided a sample on 14 October 2013 at the F35 Futures event held in El Prat, Spain. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain terbutaline, a beta-2 agonist. Terbutaline is a Prohibited Substance under the 2013 WADA List of Prohibited Substances and Prohibited Methods, and is therefore also prohibited under the Tennis Anti-Doping Programme. Mr Pérez Esteve was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Mr Pérez Esteve did not have a valid TUE for the use of terbutaline, but presented evidence that he had been prescribed terbutaline to treat a medical condition. The ITF accepted that Mr Pérez Esteve did not intend to enhance his performance through the use of terbutaline. It is a player’s strict personal duty to ensure that no Prohibited Substance enters his/her body, however as terbutaline is a ‘Specified Substance’ under the 2013 Prohibited List, there is discretion as to the sanction that is applied.

The ITF therefore confirmed Mr Pérez Esteve’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme, and determined that he be given a reprimand and no period of ineligibility. The ITF also determined that Mr Pérez Esteve’s results achieved at the F35 Futures Event should be disqualified.

The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.